SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008283
Filing Date
2024-05-15
Accepted
2024-05-15 16:01:57
Documents
69
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240331x10q.htm   iXBRL 10-Q 1514148
2 EX-31.1 tmb-20240331xex31d1.htm EX-31.1 16506
3 EX-31.2 tmb-20240331xex31d2.htm EX-31.2 13471
4 EX-32.1 tmb-20240331xex32d1.htm EX-32.1 7661
5 EX-32.2 tmb-20240331xex32d2.htm EX-32.2 6974
  Complete submission text file 0001558370-24-008283.txt   5864147

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20240331.xsd EX-101.SCH 43976
7 EX-101.CAL tmb-20240331_cal.xml EX-101.CAL 38670
8 EX-101.DEF tmb-20240331_def.xml EX-101.DEF 225980
9 EX-101.LAB tmb-20240331_lab.xml EX-101.LAB 312562
10 EX-101.PRE tmb-20240331_pre.xml EX-101.PRE 311468
73 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240331x10q_htm.xml XML 820804
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 24950164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)